Tuesday, December 6, 2016
Senate Approves Faster Approval Process for FDA
›
Feeling "trumped" lately? Yeah, we know the feeling. With the 2016 election beyond us, and a new administration among us, health...
Tuesday, October 4, 2016
Additional Rebate for Generic Products Starts Q1 2017
›
Effective with the Q1 2017 Medicaid rebates , manufacturers of non-innovator products will be subject to an inflation penalty similar to th...
Friday, September 30, 2016
AMP Final Rule: Puerto Rico in the Balance
›
The 2016 Final Rule expanded our definition of “states, allowing the five US territories to join the MDRP. John Shakow’s stimulating prese...
Wednesday, September 28, 2016
Medicaid Drug Rebate Program Summit: A Final Review
›
For the last few years, the final session at the Medicaid Drug Rebate Program Summit (MDRP) has been handled by John Shakow (King and Spal...
Monday, September 26, 2016
Unintended Consequences – AMP and 5i
›
It had humble beginnings. In 1991, Congress passed the Omnibus Budget Reconciliation Act (OBRA 90), setting up the Medicaid Drug Rebate Pro...
MDRP Pre-conference Day - Recap on the AMP Final Rule
›
A recap from the MDRP pre-conference Day on the AMP Final Rule by John Bliss, an independent government pricing consultant. I spent mo...
Friday, September 23, 2016
Farewell to 2016's MDRP Summit
›
It’s Thursday night, the 2016 Medicaid Drug Rebate Program ( MDRP) Summit has come to a close, and hopefully you are all safely at home a...
Thursday, September 22, 2016
A Review with Some of the Top GP Legal Experts
›
One of my favorite sessions each year at MDRP is the “fireside chat” with the lawyers that are experts in government pricing. (I’m still ...
MDRP 2016: Day One - Government Agency Sessions
›
The 2016 MDRP Summit is officially underway, and the theme of the morning was Government Agencies . IIR always does an excellent job recr...
Wednesday, September 21, 2016
Drug Pricing in Today’s Environment
›
MDRP ’s keynote speaker, Scott Gottlieb (Resident Fellow, American Enterprise Institute) focused on drug spending and the politics in today...
›
Home
View web version